Navigation Links
New Year's Resolution: Give Pets the Gift of Top-Notch Health Care
Date:1/14/2014

BURLINGAME, Calif., Jan. 14, 2014 /PRNewswire/ -- As pet owners drew up their lists of New Year's resolutions for 2014, there's no doubt many of them wrote: "Take better care of my furry companion." Nowadays there are pet salons, dog and cat therapists, and even designer clothes and top-brand carrying cases to take the little canine or feline darlings along wherever mommy or daddy goes. Pet parents might also feel compelled to buy some pricey toys at the pet store. But anyone who has ever lived with a dog or cat knows that most toys can't compete with that chewed-up baseball or shoe left lying around. Instead of spending the big bucks on Prada or Chanel couture for their cockapoo, pet owners should consider saving money for what really matters: the very best health care.

Keeping pets healthy starts with their owners. Feeding one's "baby" the correct food—and not letting it constantly munch on scraps from the dinner table—is step one. Many pet disorders originate from eating incompatible human foods. Step two is monitoring a pet's body and noting any changes. When a pet gets a belly rub, attention should be paid to any lumps, bumps or discolorations. A dog that limps when taken for a walk could be nothing serious—or the first sign of potentially serious medical issues. For human or beast alike, early detection is always a good way to find the ideal treatment.

One company is determined to help pet owners find those ideal treatments: Kindred Biosciences, Inc., a groundbreaking biopharmaceutical company headquartered in San Francisco. Kindred Bio is passionately dedicated to researching and developing the best medications for dogs, cats and horses.

"Our mission is simple," said Richard Chin, M.D., Kindred Bio's Founder and CEO. "We strive to bring the very best science and medicine to our animal companions." The company is currently developing a series of products including CereKin for osteoarthritis pain in dogs and horses; AtoKin for atopic dermatitis in dogs; and SentiKin for post-operative pain in dogs and horses. "We believe our research will relieve suffering and potentially save animals' lives," Chin adds.

For more information, visit www.kindredbio.com, who paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE Kindred Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Steven F. Weiner, MD, of the Aesthetic Clinique in Santa Rosa Beach, Florida, Celebrates 20 Years of Botox Experience
2. BioTechniques Publishes Special Issue to Celebrate 30 Years of Life Science Methods and Techniques
3. JULABO USA Celebrates 20 Years in the U.S.A.
4. Colonoscopy screening every ten years could prevent 40% of colorectal cancers
5. Cato Research Celebrates 25 Years of Successful Life Science Research and Development
6. Celebrate Twenty Years of Good Business
7. India Bioinformatics Industry Market Size Expected to Grow by Average Annual Growth of 14.4% in the Next 5 Years: Ken Research
8. Bayer CropScience Celebrates 150 Years of Innovation; Asks for 150 Perspectives on the Future of Farming
9. French Man Surpasses Two Years of Support with SynCardia Total Artificial Heart
10. OrganJet customer receives kidney transplant years faster due to smart multiple listing
11. Food Safety Microbiology Testing Increases 40% in 5 Years to $2.9 Billion Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):